RFI: Beacon Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management
Key Takeaways
- Approximately 1 weeks to prepare your response
- Full and open competition - all businesses eligible to bid
- Work to be performed in ABERDEEN PROVING GROU, MD
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- W911SR-26-R-BEAC
- Opportunity Type
- Sources Sought
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEPT OF THE ARMY
- Office
- W6QK ACC-APG
- Posted Date
- Friday, February 20, 2026
- Response Deadline
- Friday, March 20, 2026
- Set-Aside
- Full & Open Competition
- Place of Performance
- ABERDEEN PROVING GROU, MD, 21010-5424
- Status
- Active
Description
The Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRN Defense), through the Beacon program, is accelerating identification and screening of chemical threat medical countermeasure (MCM) candidates through a data-driven approach. Beacon will conduct targeted non-clinical, clinical, and Chemical, Manufacturing, and Controls (CMC) testing of MCM candidates to reduce the risk of failure in advanced development. Beacon will also perform studies targeting operationally relevant parameters to demonstrate effectiveness in a simulated operational environment. Beacon will establish and maintain a robust pipeline, seamlessly transitioning successful candidates to continued advanced development. This Request for Information (RFI) is to solely serve as mar
Why This Opportunity Matters
The Department of DEFENSE is conducting market research to identify potential sources for research and development in biotechnology (except nanobiotechnology) in ABERDEEN PROVING GROU, MD. Responding to this notice helps ensure your company is considered for the eventual solicitation.
Similar Opportunities
AJ11-VA Depleted Uranium Program PO 512C50314
Q-RNAscope In-House Assay
Low-cost, Connected, Digital Lateral Flow Platform to Detect Influenza A, Influenza B, and SARS-Cov -2 for use in Over-the-Counter (OTC) Settings
A-High Throughput Transcriptomics (HTTr)
human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
- Knowledge Base
- Guides
- Glossary
- Q&A
- Documentation
- Blog
- For Small Business
- For Capture Teams
- Compare Platforms
- Services
- Workflow Automation
- Support
- Contact Us